Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.89 USD | +4.88% | +10.64% | +44.83% |
May. 07 | Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday | MT |
May. 07 | Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating | MT |
Financials (USD)
Sales 2024 * | 1.22B | Sales 2025 * | 1.52B | Capitalization | 2.64B |
---|---|---|---|---|---|
Net income 2024 * | 39M | Net income 2025 * | 67M | EV / Sales 2024 * | 1.99 x |
Net cash position 2024 * | 217M | Net cash position 2025 * | 418M | EV / Sales 2025 * | 1.46 x |
P/E ratio 2024 * |
79.4
x | P/E ratio 2025 * |
44.1
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.23% |
Latest transcript on Hims & Hers Health, Inc.
1 day | +4.88% | ||
1 week | +10.64% | ||
Current month | +2.87% | ||
1 month | -7.66% | ||
3 months | +35.97% | ||
6 months | +84.14% | ||
Current year | +44.83% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 38 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 83 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 234 M€ | +2.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 12.89 | +4.88% | 7,024,804 |
24-05-10 | 12.29 | -4.88% | 7,000,486 |
24-05-09 | 12.92 | +6.34% | 10,467,561 |
24-05-08 | 12.15 | -1.62% | 12,703,632 |
24-05-07 | 12.35 | +6.01% | 25,707,767 |
Delayed Quote Nyse, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.83% | 2.64B | |
-42.23% | 2.03B | |
+115.18% | 703M | |
+12.20% | 477M | |
-46.76% | 66.88M |
- Stock Market
- Equities
- HIMS Stock